Up next

Autoplay

Long-Term Exposure to Low-Dose Prednisone With Abiraterone Acetate for mCRPC

1 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

Leonard Gomella, MD, professor, Jefferson University, physician, chair, Department of Urology, director, Kimmel Cancer Center Network, discusses results from a study that assessed the corticosteroid-associated adverse events with long-term exposure to low-dose prednisone given with abiraterone acetate to patients with metastatic castration-resistant prostate cancer (mCRPC).

Show more
0 Comments sort Sort By

Up next

Autoplay